Cargando…

Prevalence of Antiphospholipid Antibodies and Association With Incident Cardiovascular Events

IMPORTANCE: The prevalence of antiphospholipid antibodies (aPL) and their association with future atherosclerotic cardiovascular disease (ASCVD) risk has yet to be thoroughly investigated. OBJECTIVE: To determine the association between measurements of aPL at a single time point and ASCVD risk in a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuo, Yu, Navaz, Sherwin, Liang, Wenying, Li, Chun, Ayers, Colby R., Rysenga, Christine E., Harbaugh, Alyssa, Norman, Gary L., Solow, E. Blair, Bermas, Bonnie, Akinmolayemi, Oludamilola, Rohatgi, Anand, Karp, David R., Knight, Jason S., de Lemos, James A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074226/ https://www.ncbi.nlm.nih.gov/pubmed/37014642 http://dx.doi.org/10.1001/jamanetworkopen.2023.6530

Ejemplares similares

Impaired HDL Metabolism Links GlycA, A Novel Inflammatory Marker, with Incident Cardiovascular Events
por: Riggs, Kayla A., et al.
Publicado: (2019)

Cholesterol efflux capacity and its association with prevalent metabolic syndrome in a multi-ethnic population (Dallas Heart Study)
por: Akinmolayemi, Oludamilola, et al.
Publicado: (2021)

Autoantibodies stabilize neutrophil extracellular traps in COVID-19
por: Zuo, Yu, et al.
Publicado: (2021)

Health Literacy and Patient Activation in the Pediatric to Adult Transition in Systemic Lupus Erythematosus: Patient and Health Care Team Perspectives
por: Ciosek, Ashley L., et al.
Publicado: (2022)

Therapeutic recreation camps for youth with childhood-onset systemic lupus erythematosus: perceived psychosocial benefits
por: Saez, Cristina, et al.
Publicado: (2022)

Circulating Calprotectin as a Predictive and Severity Biomarker in Patients with COVID-19
por: Norman, Gary L., et al.
Publicado: (2022)

Endothelial Cell–Activating Antibodies in COVID‐19
por: Shi, Hui, et al.
Publicado: (2022)

Antiphospholipid syndrome: a clinical perspective
por: Zuo, Yu, et al.
Publicado: (2020)

Cardiovascular Lifetime Risk Predicts Incidence of Coronary Calcification in Individuals With Low Short‐Term Risk: The Dallas Heart Study
por: Paixao, Andre R. M., et al.
Publicado: (2014)

Association Between Circulating Soluble Receptor for Advanced Glycation End Products and Atherosclerosis: Observations from the Dallas Heart Study
por: Lindsey, Jason B., et al.
Publicado: (2009)

Identifying Additional Risk Factors for Thrombosis and Pregnancy Morbidities Among Antiphospholipid Antibodies Carriers
por: Zuo, Yu, et al.
Publicado: (2018)

Additional risk factors associated with thrombosis and pregnancy morbidity in a unique cohort of antiphospholipid antibody-positive patients
por: Li, Chun, et al.
Publicado: (2022)

GlycA, hsCRP differentially associated with MI, ischemic stroke: In the Dallas Heart Study and Multi-Ethnic Study of Atherosclerosis: GlycA, hsCRP Differentially Associated MI, Stroke
por: Riggs, Kayla A., et al.
Publicado: (2022)

Racial Differences in Cardiovascular Biomarkers in the General Population
por: Hackler, Eddie, et al.
Publicado: (2019)

Relation of Black Race between High Density Lipoprotein Cholesterol Content, High Density Lipoprotein Particles and Coronary Events (From the Dallas Heart Study)
por: Chandra, Alvin, et al.
Publicado: (2015)

Fertility and pregnancy in rheumatoid arthritis and systemic lupus erythematosus
por: Bermas, Bonnie L., et al.
Publicado: (2015)

Understanding the Pathophysiology of Thrombotic APS through Animal Models
por: Gandhi, Alex A., et al.
Publicado: (2021)

Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome
por: Knight, Jason S., et al.
Publicado: (2022)

Interstitial Pneumonia with Autoimmune Features: What the Rheumatologist Needs to Know
por: Joerns, Elena K., et al.
Publicado: (2022)

Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults
por: Neeland, Ian J., et al.
Publicado: (2013)

Dialogue: Hydroxychloroquine pharmacokinetic (PK) and exposure response in pregnancies with systemic lupus erythematosus: the importance of adherence for neonatal outcome
por: Bermas, Bonnie, et al.
Publicado: (2022)

Improving Knowledge of Lactation Compatibility of Antirheumatic Medications Among Providers Who Care for Patients With Rheumatic Disease
por: Mills, Brooke S., et al.
Publicado: (2021)

Hydroxychloroquine early in pregnancy and risk of birth defects: don’t throw out the baby with the bathwater
por: Bermas, Bonnie L., et al.
Publicado: (2021)

Editorial: Cardiovascular diseases in autoimmune diseases: Dyslipidemia and vascular inflammation
por: Solow, E. Blair, et al.
Publicado: (2022)

Antiphospholipid Antibodies and Antiphospholipid Syndrome during Pregnancy: Diagnostic Concepts
por: Levy, Roger A., et al.
Publicado: (2015)

The Antiphospholipid Syndrome
por: Hughes, Graham R V, et al.
Publicado: (1994)

Systemic Lupus Erythematosus Management in Pregnancy
por: Dao, Kathryn H, et al.
Publicado: (2022)

Effect of Anacetrapib on Cholesterol Efflux Capacity: A Substudy of the DEFINE Trial
por: Metzinger, Mark P., et al.
Publicado: (2020)

16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends
por: Cohen, Hannah, et al.
Publicado: (2020)

Antiphospholipid antibodies and thrombosis: pathogenesis of antiphospholipid syndrome
por: Koike, T
Publicado: (2003)

Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome
por: Devreese, Katrien M.J., et al.
Publicado: (2021)

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
por: Zuo, Yu, et al.
Publicado: (2021)

Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series
por: Madison, Jacqueline A., et al.
Publicado: (2022)

The Effect of Rituximab on Antiphospholipid Titers in Patients with Antiphospholipid Syndrome
por: Youkhana, Kimberley, et al.
Publicado: (2023)

Catastrophic Antiphospholipid Syndrome
por: El-Shereef, Rawhya R., et al.
Publicado: (2016)

“Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort
por: Liu, Tingting, et al.
Publicado: (2020)

Is It Antiphospholipid Syndrome?
por: Ditto, Maria Chiara, et al.
Publicado: (2010)

Antiphospholipid syndrome
por: Espinosa, Gerard, et al.
Publicado: (2008)

Hughes Syndrome: The Antiphospholipid Syndrome
por: Hughes, Graham R V
Publicado: (1998)

Management of Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome during Pregnancy
por: Lee, Eunyoung Emily, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r6mfrcpb4snmrir2mq5joenkoi